Published in Mol Cells on November 06, 2012
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Genomic maps and comparative analysis of histone modifications in human and mouse. Cell (2005) 18.96
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature (2010) 18.63
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Alu repeats and human genomic diversity. Nat Rev Genet (2002) 12.40
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature (2009) 9.75
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature (2011) 9.33
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell (2010) 8.74
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature (2009) 8.70
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature (2011) 8.31
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21
The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 8.08
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature (2011) 7.43
The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J (2005) 7.10
Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol (2004) 6.67
Alu repeats and human disease. Mol Genet Metab (1999) 6.64
Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature (2011) 6.48
Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01
Reverse transcriptase encoded by a human transposable element. Science (1991) 5.86
DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev (2008) 5.58
Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet (2010) 5.26
Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A (2010) 5.00
Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes. Genes Dev (2006) 4.97
Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell (2011) 4.89
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell (2009) 4.54
Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev (2011) 4.45
Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet (2011) 4.25
Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science (2000) 4.19
Somatic retrotransposition alters the genetic landscape of the human brain. Nature (2011) 4.16
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem (2003) 3.93
Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol (2012) 3.83
The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells (2004) 3.78
Evolution of the mammalian transcription factor binding repertoire via transposable elements. Genome Res (2008) 3.76
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell (2010) 3.70
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 3.60
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol (2011) 3.48
Differences between human and mouse embryonic stem cells. Dev Biol (2004) 3.30
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Alu element-mediated gene silencing. EMBO J (2008) 3.22
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol Cell Biol (2001) 2.98
Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: the Lyon repeat hypothesis. Proc Natl Acad Sci U S A (2000) 2.94
Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol (2001) 2.88
Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet (2011) 2.87
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol (2008) 2.84
X-chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet (1998) 2.82
Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol (2008) 2.79
Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res (2009) 2.75
L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev (2009) 2.68
SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet (2003) 2.55
Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics (2002) 2.49
LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet (2007) 2.13
Active Alu retrotransposons in the human genome. Genome Res (2008) 2.09
L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet (2007) 2.04
In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition. Proc Natl Acad Sci U S A (1997) 1.95
Extensive genomic copy number variation in embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.91
Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A (2011) 1.87
Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet (2011) 1.87
Alu-SINE exonization: en route to protein-coding function. Mol Biol Evol (2005) 1.81
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res (2007) 1.79
LINE-1 retrotransposition requires the nucleic acid chaperone activity of the ORF1 protein. J Mol Biol (2005) 1.78
Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition. Bioinformatics (2004) 1.77
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res (2011) 1.76
The diversity of LTR retrotransposons. Genome Biol (2004) 1.74
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res (2001) 1.64
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63
Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell (2011) 1.58
Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell (2011) 1.54
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res (2010) 1.53
Useful 'junk': Alu RNAs in the human transcriptome. Cell Mol Life Sci (2007) 1.50
L1 antisense promoter drives tissue-specific transcription of human genes. J Biomed Biotechnol (2006) 1.49
Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum Mol Genet (2011) 1.45
Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J Biol Chem (2003) 1.43
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature (2011) 1.41
Intronic Alus influence alternative splicing. PLoS Genet (2008) 1.35
RNA editing by mammalian ADARs. Adv Genet (2011) 1.34
LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene (2008) 1.33
Small RNA class transition from siRNA/piRNA to miRNA during pre-implantation mouse development. Nucleic Acids Res (2010) 1.27
High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res (2009) 1.23
SVA retrotransposons: Evolution and genetic instability. Semin Cancer Biol (2010) 1.20
Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem (2011) 1.18
Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing. PLoS One (2010) 1.15
Nucleosome positioning by human Alu elements in chromatin. J Biol Chem (1995) 1.15
Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol (2010) 1.14
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol (2009) 11.18
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet (2009) 10.54
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009) 8.97
Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol (2009) 7.59
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol (2009) 6.76
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
Generation of induced pluripotent stem cells from human blood. Blood (2009) 4.92
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (2010) 3.36
Reprogramming of T cells from human peripheral blood. Cell Stem Cell (2010) 2.93
A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature (2009) 2.88
Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One (2011) 2.86
Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation (2009) 2.86
Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (2011) 2.82
A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. PLoS Genet (2009) 2.78
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature (2010) 2.36
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
Overcoming reprogramming resistance of Fanconi anemia cells. Blood (2012) 2.07
Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev (2010) 1.77
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol (2011) 1.72
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation (2012) 1.69
Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood (2010) 1.66
Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol (2010) 1.65
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63
PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol (2003) 1.62
Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A (2012) 1.62
IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol (2003) 1.56
Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proc Natl Acad Sci U S A (2012) 1.56
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell (2010) 1.49
Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells (2012) 1.32
In vitro generation of germ cells from murine embryonic stem cells. Nat Protoc (2006) 1.22
Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci (2009) 1.22
A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem (2006) 1.16
Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood (2010) 1.15
Cell cycle adaptations of embryonic stem cells. Proc Natl Acad Sci U S A (2011) 1.11
Induced pluripotent stem cells for neural tissue engineering. Biomaterials (2011) 1.11
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci Transl Med (2013) 1.11
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. J Virol (2010) 1.01
X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports (2014) 0.94
Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J (2012) 0.93
Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol (2012) 0.93
Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood (2013) 0.90
Therapeutic approaches for shankopathies. Dev Neurobiol (2013) 0.90
Debugging cellular reprogramming. Nat Cell Biol (2007) 0.88
MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. PLoS One (2013) 0.87
Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplant (2012) 0.86
Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Hum Mol Genet (2013) 0.86
Excision of a viral reprogramming cassette by delivery of synthetic Cre mRNA. Curr Protoc Stem Cell Biol (2012) 0.85
Transformation of somatic cells into stem cell-like cells under a stromal niche. FASEB J (2013) 0.84
Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells. Int J Cardiol (2012) 0.84
Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts. J Proteome Res (2011) 0.82
Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol (2013) 0.82
Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Arch Pharm Res (2012) 0.80
Cellular reprogramming: a novel tool for investigating autism spectrum disorders. Trends Mol Med (2012) 0.78
Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. J Vis Exp (2012) 0.78
Investigation of Rett syndrome using pluripotent stem cells. J Cell Biochem (2013) 0.78
The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle (2012) 0.77
Correction: Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice. PLoS One (2015) 0.76
Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family. Stem Cell Reports (2016) 0.76
Trivalent chromatin marks the way in. Cell Stem Cell (2013) 0.75
Research highlights. Regen Med (2010) 0.75
Research highlights. Regen Med (2011) 0.75
Neural Stem Cells Restore Hair Growth Through Activation of the Hair Follicle Niche. Cell Transplant (2016) 0.75